Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease

MA Farrell, HP McAdams, JE Herndon, EF Patz Jr - Radiology, 2000 - pubs.rsna.org
PURPOSE: To determine the accuracy of 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG)
positron emission tomography (PET) in the evaluation of regional lymph nodes in patients …

Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emission tomography (PET).

A Guhlmann, M Storck, J Kotzerke, F Moog… - Thorax, 1997 - thorax.bmj.com
BACKGROUND: A study was undertaken to investigate the accuracy of positron emission
tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) in the thoracic lymph node …

The role of FDG-PET scan in staging patients with nonsmall cell carcinoma

RJ Cerfolio, B Ojha, AS Bryant, CS Bass… - The Annals of thoracic …, 2003 - Elsevier
BACKGROUND: To assess the role of flourodeoxyglucose–positron-emission tomography
(FDG-PET) scan in staging patients with nonsmall cell lung cancer (NSCLC). METHODS …

Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients

K Takamochi, J Yoshida, K Murakami, S Niho, G Ishii… - Lung cancer, 2005 - Elsevier
BACKGROUND:: The evidence of clinical value of positron emission tomography (PET) with
fluorine-18 fluorodeoxyglucose (FDG) in lymph node (LN) staging in non-small cell lung …

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.

JF Vansteenkiste, SG Stroobants… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE To compare the accuracy of computed tomography-(CT) scan and the
radiolabeled glucose analog 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission …

FDG-PET in the locoregional lymph node staging of non-small cell lung cancer: a comprehensive review of the Leuven lung cancer group experience

JF Vansteenkiste, LA Mortelmans - Clinical Positron Imaging, 1999 - Elsevier
Exact staging of locoregional lymph node (LN) disease in non-small cell lung cancer
(NSCLC) is of considerable clinical interest. Computed tomography (CT) is not very accurate …

Occult nodal metastasis in patients with non‐small cell lung cancer at clinical stage IA by PET/CT

HK Park, K Jeon, WJ KOH, GY Suh, H Kim… - …, 2010 - Wiley Online Library
Background and objective: The introduction of 18F‐FDG PET/CT has enhanced the
diagnostic accuracy of nodal staging for non‐small cell lung cancer (NSCLC). We analysed …

Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings

J Konishi, K Yamazaki, E Tsukamoto, N Tamaki… - Respiration, 2003 - karger.com
Background: Accurate staging of mediastinal and hilar lymph nodes is a critical factor
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases

JF Vansteenkiste, SG Stroobants, PR De Leyn… - Chest, 1997 - Elsevier
Study objective To compare the performance of CT, radio-labeled 18 F-fluoro-2-deoxy-D-
glucose positron emission tomography (FDG-PET) blinded to CT, and FDG-PET visually …

PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma

AJ Poncelet, M Lonneux, E Coche… - European journal of …, 2001 - academic.oup.com
Objective: To assess the effectiveness of positron emission tomography with radiolabeled
[18F]-2-fluoro-deoxy-d-glucose (PET-FDG) imaging in mediastinal lymph node (LN) staging …